ABSTRACT
OBJECTIVE：To compare the protective effect of atomization inhalation and intraperitoneal injection of edaravone on acute lung injury in smoke inhalation lung injury model rats. METHODS ：Thirty male SD rats were divided into normal control group（group A ），injury group （group B ），intraperitoneal injection group （group C ），low-dose aerosol inhalation group （group D），high-dose aerosol inhalation group （group E ）according to random numble table ，with 6 rats in each group. Group B-E were placed in smoke generator containing pine sawdust to induce smoke inhalation lung injury model. In group A ，the operation was the same as above except that the pine sawdust was not placed. Thirty minutes after modeling ，group C were injected intraperitoneally with edaravone 18 mg/kg（every 70 min，4 times in total ）. Group D and E inhaled edaravone 9，1.8 mg/kg（every 60 min，lasting for 10 min each time ，4 times in total ）. The rats were treated by no means in group A and group B. Six hours after last medication，arterial blood gas analysis was performed ，and the lung wet to dry ratio （W/D）and water content of lung tissue were calculated. The levels of TNF-α，IL-6 and IL- 10 in serum were detected by double antibody ELISA. The contents of MDA ，MPO， SOD and Caspase- 3 in lung tissue were determined by ELISA and other methods. HE staining was used to observe the pathological changes of lung tissue. The apoptotic rate of cells in lung tissue were determined by TUNEL assay. RESULTS ：No abnormality was found in lung tissue of group A ；in group B ，hemorrhage and edema were found in lung tissue ，alveolar structure was difficult to identify，and inflammatory cells and red blood cell infiltration were seen. Above symptoms of rats in group C-E were improved to different extent. Compared with group A ，PaO2/FiO2 and SOD content of lung tissue were decreased significantly in other groups （P＜0.05）；water content of lung tissue ，W/D，serum contents of TNF-α，IL-6 and IL- 10，the contents of MDA ，MPO and Caspase-3 in lung tissue ，apoptotic rate were increased significantly （P＜0.05）. Compared with group B ，PaO2/FiO2 and serum contents of IL- 10 were increased significantly in administration groups （P＜0.05）；water content of lung tissue ，W/D，serum contents of TNF-α and IL-6，the contents of MDA ，MPO and Caspase- 3 in lung tissue ，apoptotic rate were significantly decreased，in dose-dependent manner （P＜0.05）. CONCLUSIONS ：Edaravone has a certain protective effect on smoke inhalation lung injury model rat. It can reduce the production and release of inflammatory mediators and/or cytokines ，reduce the peroxide damage and inhibit cell apoptosis in a dose-dependent manner. The effect of atomization inhalation is more obvious than that of intraperitoneal injection.
ABSTRACT
OBJECTIVE：To evaluate the efficacy and safety of atomization inhalation of polymyxin combined in the adjunctive treatment for ventilator-associated pneumonia ，and to provide evidence-based reference for clinical treatment. METHODS ： Retrieved from Cochrane Library ，Embase，PubMed，Web of Science ，CNKI，CBM，VIP and Wanfang database （from their inception to March 2021），randomized controlled trials （RCTs）about efficacy and safety of atomization inhalation of polymyxin combined with conventional treatment （trial group ） versus conventional treatment （control group ） for ventilator- associated pneumonia were collected. After data extraction and quality evaluation of included literatures met inclusion and exclusion criteria ， Meta-analysis was performed by using Rev Man 5.4 software. RESULTS ：A total of 13 clinical studies were included ，involving 2 RCTs and 11 cohort studies with a total of 1 066 patients. The results of Meta-analysis showed that clinical response rate [OR ＝ 1.53，95％CI（1.17，2.00），P＝0.002]，microbial clearance rate [OR ＝1.46，95％CI（1.11，1.91），P＝0.007] of trial group were significantly higher than those of control group ，with statistical significance. There was no statistical significance in the mortality rate [OR ＝0.88，95％CI（0.68，1.14），P＝0.32] and the incidence of renal impairment [OR ＝1.04，95％CI（0.72，1.49），P＝0.85] between 2 groups. CONCLUSIONS ：Based on current evidence ，atomization inhalation of polymyxin combined with conventional treatment can significantly improve clinical response rate and microbial clearance rate of patients with ventilator- associated pneumonia. However ， more strictly-designed ， long-term follow-up and large-scale RCTs are needed.
ABSTRACT
Objective To investigate the effect of atomization inhalation of budesonide and terbutaline sulfate on serum levels of cyclcoxygenase 2 (COX-2) and chemokine like factor-1 (CKLF-1) in children with bronchial asthma.Methods A total of 78 children with bronchial asthma in Hangzhou Children's Hospital from April 2016 to August 2017 were selected and divided into the control group(n =39) and the study group(n =39).The control group was treated with routine treatment,and the study group was treated with budesonide and terbutaline sulfate on the basis of the control group.The treatment was continued for 7 d.After t treatment,the clinical effects,clinical symptoms improvement,hospitalization time,the serum levels of COX-2 and CKLF-1 before and after treatment,and the incidence of adverse reaction of two groups were observed.Results The total effective rate of the study group(94.87％) was higher than that of the control group (74.36％)(x2 =6.303,P ＜ 0.05).The improvement time of chest tightness,wheezing,cough and hospitalization time of the study group were shorter than those of the control group (t1 =13.054,t2 =7.365,t3 =4.944,t4 =8.342,all P ＜ 0.05).After treatment,the levels of serum COX-2 and CKLF-1 in the two groups were lower than those before treatment,which of the study group were lower than those in the control group(t1 =4.934,t2 =4.660,all P ＜0.05).There was statistically significant difference in the incidence rate of adverse reactions between the study group(12.82％) and the control group(7.69％) (x2 =0.139,P ＞ 0.05).Conclusion Atomization inhalation of budesonide and terbutaline sulfate in the treatment of children with bronchial asthma can effectively alleviate the clinical symptoms,reduce serum levels of COX-2 and CKLF-1,improve therapeutic effect,promote children's recovery and shorten the hospitalization time.Besides,the incidence rate of adverse reactions is low,and it is safe.
ABSTRACT
Objective To investigate the clinical value of atomization inhalation combined with montelukast in the treatment of infantile cough after infection.Methods From September 2015 to August 2017,300 children with post-infection cough in Taizhou Tumor Hospital were randomly divided into two groups,with 150 cases in each group.The control group was treated with montelukast,and the observation group was given atomization inhalation combined with montelukast.The clinical effect,symptom improvement time,adverse events and parents' satisfaction were observed.Results The total effective rate of the observation group was 97.33％,which was higher than 86.67％ in the control group(P ＜0.05).The improvement time of cough and expectoration of the observation group [(3.02 ± 0.45)d,(2.11 ± 0.71)d] was better than those of the control group(all P ＜ 0.05).The incidence rate of adverse events in the observation group(3.33％) was lower than that in the control group(P ＜0.05).The total satisfactory rate of parents in the observation group was 96.00％,which was obviously higher than that in the control group(P ＜ 0.05).Conclusion The effect of atomization inhalation combined with montelukast on children's cough after infection is good,it can effectively control the condition and relieve the symptoms such as cough,and the safety is higher.The risk of adverse reactions is low.
ABSTRACT
Objective To observe and analyze the clinical effect of noninvasive sputum aspiration combined with atomization inhalation in the treatment of pediatric bronchiolitis. Methods Totally 79 children with bronchiolitis diagnosed from January 2016 to December 2017 were selected. The children were divided into observation group (40 cases) and control group (39 cases) by double blind method of stratified random sampling. The observation group were treated with atomization inhalation after noninvasive sputum aspiration;and the control group were treated with the traditional inhalation of sputum according to the condition of the disease.The improvement effect of the symptoms before and after the treatment of the two groups was compared. Results After treatment, the improvement of symptoms in the two groups included cough, fever, wheezing, shortness of breath, lung rales, daily sputum aspiration and hospital stay were (5.34±1.06) d, (1.82±0.35) d, (2.66±0.85) d, (1.76±0.39) d, (4.37±1.29) d, (6.38± 1.39) times, (6.31 ± 0.82) d in the observation group, (6.25 ± 0.98) d, (2.34 ± 0.41) d, (3.08 ± 0.94) d, (2.56 ± 0.41) d, (5.39 ± 1.33) d, (8.31 ± 1.52) times, (8.25 ± 1.09) d in the control group, the difference was statistically significant( t=2.084-8.954, P<0.05). Respiratory function improvement including arterial oxygen saturation,heart rate,respiratory rate was 0.96±0.03, (110.85±4.16) times/min, (29.49±1.87) times/min in the observation group, 0.92±0.03, (119.34±4.22) times/min, (35.14±1.95) times/min in the control group,the difference was statistically significant(t=5.925, 9.005, 13.146, P<0.05). The effective rate of the observation group was 97.50％ (39/40), which was significantly higher than that of the control group 79.49％(31/39), the difference was statistically significant (χ2=4.688, P<0.05).The satisfaction rate of the family members of the observation group of the nebulization and sputum suction service was 100.00％(40/40), which was significantly higher than that of the control group (87.18％, 34/39), the difference was statistically significant (χ2=13.698, P<0.05). Conclusions Noninvasive sputum aspiration combined with atomization inhalation is effective in the treatment of pediatric bronchiolitis. It can relieve airway obstruction, improve asthma symptoms, shorten the time of hospitalization, and the operation is convenient and safe.
ABSTRACT
Objective To evaluate the efficacy of early controlled cold atomization inhalation of budesonide in the treatment of post-operative sore throat (POST) after double-lumen endotracheal intubation. Methods A total of 105 ASAⅠ~Ⅲpatients having POST after thoracic surgery with double-lumen endotracheal intubation were randomly divided into three groups(n = 35 each). The patients in the control group were treated with atomization inhalation of 12 mL 20℃saline(Group C)and those in the observation groups were treated with 10 mL 20℃saline plus 2 mL(1 mg)budesonide(Group R)or 10 mL 0℃saline plus 2 mL(1 mg)budesonide (Group L)for 15 minutes immediately after extubation. The 4-score scale was used to evaluate sore throat,dry throat,hoarseness and swallowing difficulty 1,2,6 and 24 h after the extubation and QoR-40 scale to assess post-operative recovery at 24 h. Results The scores of sore throat and dry throat were significant lower in group L than those in group C(P < 0.05)at 1,2 and 24 h and the score of swallowing difficulty(dysphagia)was also signifi-cant relieved at 1,6 and 24 h after the extubation in group L. Furthermore,the score of sore throat was significant lower in group L than that in group R(P<0.05)at 1 h. There were no significant differences of hoarseness in three groups(P > 0.05). The total score of QoR-40 scale was the significantly highest in group L than that in group C and group R(P<0.05)24 h postoperatively. Conclusion Cold atomization inhalation of budesonide immediately after the extubation of double-lumen endotracheal can alleviate POST and bring more benefits to patients which help to enhance the recovery after throracic surgery.
ABSTRACT
Objective To investigate the effects of aerosol inhalation on respiratory mechanical parameters under different ventilation patterns and ventilator parameters in patients on mechanical ventilation and simulated model of aqualung in vitro. Methods ① Clinical research: the patients needed sedative undergoing mechanical ventilation admitted to intensive care unit (ICU) of Qingdao Municipal Hospital from January 2016 to January 2018 were enrolled. They were randomly divided into volume controlled ventilation (VCV) group and pressure controlled ventilation (PCV) group according to random number table. Main parameters setting of respirator: the predetermined tidal volume (VT) was set at 500 mL in the VCV group; the preset pressure was regulated, so that when the atomizer was connected to the atomization device, the VT was nearly equal to or slightly larger than 500 mL in the PCV group. Respiratory mechanical indices [peak airway pressure (Ppeak), inspiratory tidal volume (VTi), exhaled tidal volume (VTe)] were recorded before atomization (atomized oxygen flow was 0) and 10 minutes after the beginning of atomization under the condition of 7 L/min and 9 L/min of atomized oxygen flow respectively. ② Simulated scuba test in vitro: the ventilator was connected to the simulated scuba, and an external mechanical ventilation model was constructed. They were divided into VCV group and PCV group according to ventilation mode. Main parameters setting of respirator: VCV group was given 450, 550, 650 mL preset VT, and PCV group was given 12, 16, 20 cmH2O (1 cmH2O = 0.098 kPa) preset suction pressure. The changes in respiratory mechanical indexes were observed under different ventilation patterns and ventilator parameters of 0 (only connected with atomizing device), 5, 7, 9 L/min atomizing oxygen flow. Results ① Clinical research results: all 77 patients were enrolled in the final analysis, including 20 patients with 7 L/min of atomized oxygen flow under VCV mode, 18 patients with 9 L/min of atomized oxygen flow, and 21 patients with 7 L/min of atomized oxygen flow under PCV mode and 18 patients with 9 L/min of atomized oxygen flow. Under VCV mode, the levels of Ppeak and VTe were increased with the increase in atomized oxygen flow, and there was significant difference at 9 L/min as compared with those before atomization [Ppeak (cmH2O): 29.44±4.58 vs. 24.39±4.64, VTe (mL): 896.26±24.91 vs. 497.61±8.67, both P < 0.05]. There was no significant change in VTi, and no significant difference at 9 L/min of atomized oxygen flow as compared with that before atomization (mL: 494.67±3.07 vs. 492.61±6.05, P > 0.05). Under PCV mode, with the increase in oxygen atomization flow, VTi was decreased gradually, and VTe was increased gradually, with significant difference as compared with those before atomization when the atomized oxygen flow was 9 L/min [VTi (mL): 322.78±17.75 vs. 518.17±8.97, VTe (mL): 730.89±31.20 vs. 519.00±9.06, both P < 0.05]. There was no significant change in Ppeak, and no significant difference at 9 L/min of atomized oxygen flow as compared with that before atomization (cmH2O: 21.44±2.23 vs. 21.39±2.55, P > 0.05). ② Simulated scuba results in vitro: under VCV mode, VTe monitored by respirator and VT showed by simulated scuba in different preset VT groups were continuously increased with the increase in oxygen atomization flow, while VTi monitored by ventilator was not significantly changed. At 10 minutes after the beginning of atomization, the VTi monitored by ventilator in different preset VT groups was significantly lower than VT showed by simulated water lung (mL: 649.67±5.03 vs. 840.00±10.00 at 650 mL of preset VT and 9 L/min of atomized oxygen flow, P < 0.05), and VTe was significantly higher than VT showed by simulated water lung (mL: 1 270.33±11.06 vs. 840.00±10.00 at 650 mL of preset VT and 9 L/min of atomized oxygen flow, P < 0.05). Under PCV mode, with the increase in atomized oxygen flow, VTi monitored by ventilator in different preset suction pressure groups was decreased gradually, and VTe was increased gradually, but Ppeak monitored by ventilator did not changed significantly. At 10 minutes after the beginning of atomization, the VTi monitored by ventilator in different preset suction pressure groups was significantly lower than VT showed by simulated water lung (mL: 917.33±4.51 vs. 1 103.33±5.77 at 20 cmH2O of preset suction pressure and 9 L/min of atomized oxygen flow, P < 0.05), and VTe was significantly higher than VT showed by simulated water lung (mL: 1 433.33±4.73 vs. 1 103.33±5.77 at 20 cmH2O of preset suction pressure and 9 L/min of atomized oxygen flow, P < 0.05). Conclusions Under the VCV mode, the oxygen flow outside the atomization could lead to the increase in VT of the patient side, while under the PCV mode, the VT and Ppeak in the patient side had no significant change. Both VTi and VTe monitored by ventilator could not reflect the patient's VT under either VCV or PCV mode.
ABSTRACT
Objective To investigate the influence of conventional and high dose of interferon atomization inhalation on the short-term clinical efficacy,lung function and adverse effects of children with bronchiolitis.Methods 160 children with bronchiolitis were chosen and randomly divided into two groups,80 cases in each group.On the basis of salbutamol inhalation,A group was given recombinant interferon α-2b for 200 000 IU · kg-1 · d-1,and B group was given recombinant interferon α-2b for 400 000 IU · kg-1 · d-1.The short-term clinical efficacy,the disappeared time of symptoms and signs,the hospital staying time,the disease severity score,the levels of RR and SpO2 before and after treatment and the incidence of adverse effects were compared between the two groups.Results The excellence effects and total clinical effects of B group were significantly higher than those of A group(x2 =7.27,P ＜ 0.05).The disappeared time of symptoms and signs and hospital staying time of B group were significandy shorter than those of A group(t =2.78,2.65.3.04,2.19,all P ＜ 0.05).Mter treatment,the disease severity scores of B group were significantly lower than those of A group and before treatment(t =2.43,2.13,2.55,2.07;3.02,3.41;3.11,3.65;2.81,3.30;2.87,3.15;all P ＜ 0.05).After treatment,the indicators of pulmonary ventilation function of B group were significantly lower than those of A group and before treatment(t =2.35,2.20,2.73,3.04;2.49,2.97,all P ＜ 0.05).There was no statistically significant difference in the incidence rate of adverse effects between the two groups(x2 =1.26,P ＞ 0.05).Conclusion Compared with conventional dose of interferon,high dose interferon atomization inhalation in the treatment of children with bronchiolitis can effectively higher the disease control effects,speed up the disease rehabilitation process,improve the pulmonary ventilation function and without aggravate drug adverse reactions.
ABSTRACT
Objective To analyze and discuss the negative effects of atomization inhalation in mechanical ventilation patients in intensive care unit. Methods A retrospective study of all the mechanical ventilation patients in the general ICU of our hospital was carried out from Aprilto December 2015. The risk of multidrug-resistant organisms(MDROs)colonizationin the lower respiratory tract and ventilation associated pneumonia(VAP)in mechanical ventilation patients were analyzed. Results A total of 922 patients were monitored, 160 of whom had atomization inhalation, 92 for MDROs colonizationin the lower respiratory tract and 18 for VAP. The rates ofatomization inhalation in patients with and without MDROs colonizationin the lower respiratory tract were 30.4%(28/92)and 15.9%(132/830)with statistical difference (χ2=12.193, P=0.000). And those in patients with and without VAP were 50.0%(9/18) and 16.7%(151/904), with statistical difference (χ2=11.420, P=0.000). Atomization inhalation was the independent risk factor both of MDROs colonizationin the lower respiratory tract(OR=1.917, 95%CI1.163-3.159, P=0.011) and VAP(OR=4.613, 95%CI 1.773-12.002, P=0.000) in mechanical ventilation patients. Conclusions Atomization inhalation may increase the risk of MDROs colonizationin the lower respiratory tract and VAP in mechanical ventilation patients. Thus unnecessary and too frequent operations of atomization inhalation should be decreased.
ABSTRACT
Objective To study the clinical effects of inhalation of albuterol and the treatment of chronic obstructive pulmonary disease in the treatment of chronic obstructive pulmonary disease.Methods Choose 88 cases of patients treated in our hospital, it can be divided into two groups, separately carries on the routine therapy, salbutamol aerosol inhalation therapy, and routine health education and psychological intervention.The clinical outcomes and anxiety were analyzed in the two groups.Results The curative effect of observation group, anxiety, improve the situation, obviously better than the control group, all the data through a detailed comparison between groups, the difference was statistically significant(P<0.05).Conclusion Chronic obstructive pulmonary disease, the use of albuterol atomization inhalation and combined psychological intervention, the treatment effect is good.
ABSTRACT
OBJECTIVE:To investigate the optimal administration route of ambroxol in the treatment of pediatric respiratory disease. METHODS:Totally 120 children with respiratory disease in pediatric department of our hospital during Jun. 2014-Jun. 2016 were divided into intravenous dripping group and atomization inhalation group according to even and odd-numbered admission order,with 60 cases in each group. Intravenous drip group was given Ambroxol hydrochloride injection 7.5 mg dissolved in 5%glucose solution 50 mL,ivgtt,bid;aerosol inhalation group was given aerosol inhalation of Ambroxol hydrochloride injection 7.5 mg,for 15 min each time,bid. The two groups were treated with 7 d. Clinical efficacies,p(O2)and p(CO2)level,the times of sputum absorption,clinical indexes and the occurrence of ADR were compared between 2 groups. RESULTS:Total response rate of atomization inhalation group(96.67%)was significantly higher than intravenous dripping group(78.33%);p(O2)level was sig-nificantly higher than intravenous dripping group,while the times of sputum absorption,fever disappearance time,asthma disap-pearance time,oxygen therapy time,pulmonary rales disappearance time,cough disappearance time and average hospitalization time were significantly less or shorter intravenous dripping group,with statistical significance (P0.05). CONCLUSIONS:Ambroxol is effective in the treatment of pediatric respiratory disease,and clinical efficacy of atomization inhalation is better than intravenous drop.
ABSTRACT
Objective To investigate the effect of combined inhalation of ambroxol hydrochloride, intermittent tapping and sputum drainage and psychological intervention on postoperative lung cancer. Methods 68 cases of lung cancer patients treated in our hospital from January 2015 to March 2017 were selected, the control group received oxygen aerosol inhalation of ambroxol hydrochloride and intermittent beating back sputum at the early stage of the operation. The study group was treated with psychological intervention on the basis of the treatment of the control group. The postoperative pulmonary complications in two groups of patients with lung cancer were recorded. The data were input into SPSS statistical software and analyzed. Results The incidence rate of atelectasis and pulmonary infection in the study group (5.88％, 8.82％) were higher than those in the control group (The incidence of atelectasis was 32.35％, and the incidence of pulmonary infection was 38.24％) was significantly reduced, the difference was statistically significant (P<0.05). Conclusion On the basis of providing oxygen aerosol inhalation of ambroxol hydrochloride and intermittent beating back sputum for early postoperative lung cancer patients, the clinical prognosis can be significantly improved if psychological intervention is used.
ABSTRACT
Objective:To research the curative effect of moxifloxacin solution atomization inhalation in the treatment of chronic obstructive pulmonary disease (COPD) combined with respiratory failure.Methods:94 cases of COPD patients combined with respiratory failure from May 2014 to May 2016 were selected and divided into the control group(n=47) and the research group (n=47) acording to the lottery method,the control group received routine treatment,while the research group was treated based on the control group with moxifloxacin solution inhalation treatment.The curative effect,serum tumor necrosis factor-α(TNF-α),c-reactive protein (CRP) and interleukin 10 (IL-10),creatine phosphokinase (CK),aspertate aminotransferase (AST) levels,the blood oxygen partial pressure (PaO2),CO2 partial pressure (PaCO2),APACHE Ⅱ score and occurrence of adverse reactions were compared between two groups.Results:After treatment,the total effective rate of research group was higher than that of the control group (P＜0.05).The serum levels of TNF alpha,CRP,PaCO2,CK,AST,APACHE Ⅱ score of research group were evidently lower than those of the control group (P＜0.05).The serum levels ofIL-10,PaO2 of research group were evident higher than those of the control group (P＜0.05).The occurrence of adverse reactions showed no differences between the two groups (P＞0.05).Conclusion:Moxifloxacin solution atomization inhalation was effective in the treatment of COPD combined with respiratory failure,which might be related to the inhibition of inflammatory response,and improvment of breath.
ABSTRACT
OBJECTIVE:To evaluate the role of PDCA cycle management on standardizing clinical use of atomization inhala-tion drug. METHODS:Using a retrospective method,300 medical records of atomization inhalation drug use were collected from our hospital during Jan.-Dec. in 2013(non-intervention group),200 medical records collected during Apr.-Jun. in 2014(one cycle intervention group),and 180 medical records collected during Oct.-Dec. in 2014(two rounds of cycle intervention group). The use of atomization inhalation drugs was compared before and after the application of PDCA cycle management. Before and after two cy-cle intervention,4 types of medical staff were investigated on cognition of the related knowledge of atomization inhalation drugs, as physicians,pharmacists,nurses and mechanic. RESULTS:After two rounds of PDCA cycle management and intervention,the proportion of unsuitable route of administration of antibiotics,long acting glucocorticoid,non-atomization inhalation dosage form of resolving phlegm drugs,protease decreased from 54.0%,62.0%,59.7%,44.7% before intervention to 0.6%,1.1%,15.0%, 1.1% after intervention;those phenomena had not been found,such as unsuitable route of administration of TCM injection and non-atomization dosage form of theophyllines,unsuitable atomization frequence,unsuitable indication,drug mixture for preventing and controlling symptom,etc. The proportion of medical staffs being familiar with medical device,drug classification,drug selec-tion for prerention and treatment and the proportion of hospital drug stock to 93.4%,86.7%,92.4%,96.2% after intervention from 38.0%,79.0%,49.0%,39.5%before intervention. CONCLUSIONS:The application of PDCA cycle management can effec-tively regulate the use of atomization inhalation drugs in our hospital;the method can be promoted and applied.
ABSTRACT
OBJECTIVE:To compare clinical efficacy and safety of budesonide and beclometasone assisting with terbutaline by atomization inhalation in the treatment of acute pediatric asthma attack. METHODS:150 pediatric patients with acute asthma attack were randomly divided into group A and group B,with 75 cases in each group. Both group received symptomatic support treatment as low-flow oxygen inhalation,eliminating phlegm,relieving a cough,dilating bronchus and anti-infection,and atomization inhala-tion of budesonide,1 ml each time,bid. Based on this,group A was given atomization inhalation of budesonide,2 ml each time, bid;group B was given atomization inhalation of beclometasone,2 ml,bid. Treatment course of 2 groups lasted for 7 d. Clini-cal efficacy,asthma control,PEF% and the occurrence of ADR were observed in 2 groups;the time of symptoms and signs dis-appearance and hospitalization time were recorded,and symptoms and signs of children were scored 1 day before treatment and 7 days after treatment. RESULTS:During treatment,2 cases and 3 cases were withdraw from the test in group A and group B, respectively. The total effective rates of group A and B were 91.78% and 94.44%,and the rate of asthma control 95.89% and 94.44%,without statistical significance(P>0.05). The time of breathing difficulties disappearance,cough disappearance time, wheezing disappearance time and hospitalization time of group A were separately (2.11 ± 0.54),(3.28 ± 0.93),(4.38 ± 1.05), (5.83±1.29)d;those of B group were separately(2.07±0.52),(3.30±0.96),(4.45±1.08),(5.90±1.33)d,there was no sig-nificant difference between 2 groups(P>0.05). The clinical symptoms and signs score of group A before and after treatment were separately (4.28 ± 0.94) and (0.15 ± 0.04);those of before and after treatment of group B were separately (4.23 ± 0.91) and(0.11±0.03). There was significant difference before and after treatment(P0.05). The PEF% of group A before and after treatment were separately (51.4 ± 9.8)% and (67.2 ± 11.2)%;those of before and after treatment of group B were separately(52.0±7.1)%and(68.3±8.7)%. There was significant difference before and after treatment (P0.05). No obvi-ous ADR was found in 2 groups. CONCLUSIONS:Budesonide and beclometasone assisting with terbutaline by atomization inha-lation in the treatment for acute pediatric asthma attack possess the same effects and can efficiently relieve symptoms and signs, increase the rate of asthma control and shorten the rehabilita-tion course with good safety.
ABSTRACT
To compare the clinical efficacy and safety of atomization inhalation of epinephrine combined with budes-onide and dexamethasone in the treatment of children with acute laryngitis. Methods:Totally 68 cases of children with acute laryngitis were randomly divided into two groups. The two groups were given the conventional therapy, and 30 cases in the control group were giv-en dexamethasone inhalation additionally, and the treatment group was given epinephrine combined with budesonide inhalation addition-ally. The clinical effect in 12, 24 and 72h, clinical symptom disappearance time and adverse reactions in the two groups were ob-served. Results:The clinical effect of the treatment group in 12, 24 and 72h was better than that in the control group. 72h after the treatment, 17 cases in the control group were cured, and the curative rate was 56. 67%, while 27 cases in the treatment group were cured with the curative rate of 71. 05%. The disappearance time of dyspnea and stridor, barking cough, hoarseness and the other clini-cal symptoms in the treatment group was significantly shorter than that in the control group, and the difference was statistically signifi-cant (P<0. 05). The two groups had no obvious adverse reaction. Conclusion:The clinical effect of the combination of epinephrine and budesonide inhalation in the treatment of children with acute laryngitis is better than that of dexamethasone inhalation, and the combination is safe and effective, which is worthy of clinical application.
ABSTRACT
Objective To observe the clinical effect of Oxygen Atomization Inhalation combinated with Tra -ditional Chinese Medicine (TCM) in the treatment of capillary bronchitis .Methods 82 Children with capillary bronchitis were divided into Observation Group (42 cases) and contral group (40 cases).Cases in the Observation Group underwent TCM Agreement medicinal broth and oxygen atomization inhalation , while cases in the contral group underwent Ribavirin atomization .The symptoms of disappear time of signs , clinical effect and adverse circumstance were observed.Results The total efficiency of the observation group was 95.2%, 80% in the contral group.The antifebrile time, disappear time of cough and dyspnea , of the observation group were better than that in the compari -son group.The difference was statistical significant (p <0.05).There was no obvious adverse reactions during the treating periods.Conclusion The clinical effect of Oxygen Atomization Inhalation with Traditional Chinese Medicine (TCM) Agreement Medicinal Broth on capillary bronchitis is confirmed , and the effect of Relieving symptoms , signs quickly and shorten disease time is obviously better than Pure western medicine treatment .In addition, the adverse reactions caused by medicine is also very small ,which is worth promoting for clinical application .
ABSTRACT
Objective To explore the clinical effects of atomization inhalation pulmicort respules in treatment with pediatric acute infectious laryngitis. Methods 104 cases with pediatric acute infectious laryngitis admitted in Xiaoshan Hospital of Zhejiang Province from January 2011 to July 2013 were radomly divided into experimental group(n=52)and control group(n=52). Patients in experimental group were given atomization inhalation pulmicort respules,and patients in control group were received dexamethasone by intravenous injection. The symptom improvement,disappearing times of symptoms and therapeutic effect in two groups were observed and compared. Results Compared with control group,the improvement scores were higher,and disappearing time of symptoms were shorter in experiment group(P<0.05). The therapeutic effect in experimental group was up to 100%, while control group was 90.74%,and the difference between them was statistically significant(P<0.05). Conclusion Compared with dexamethasone, atomization inhalation pulmicort respules has advantages in treatment with pediatric acute infectious laryngitis,with better efficacy,shorter treatment time and fewer side effects.
ABSTRACT
Objective To investigate the clinical efficacy of Budesonide spray atomization inhalation on ear-nose-pharyngeal-throat acute inflammation.Methods 120 patients with ear-nose-pharyngeal-throat acute inflammation were slected from April 2010 to April 2013 in Liuzhou People’s Hospital.They were randomly divided into control group(n=60 )and observation group (n=60 ).The patients in observation group were treated with budesonide spray atomization inhalation,while the patients in control group were treated with conventional ultrasonic aerosol inhalation,continous use for 5 days.Compare the improvement of throat pain,pharyngeal foreign body sensation,dyspnea,hoarseness and the average improving time after treatment in two groups. Results The total effective rate of throat pain,pharyngeal foreign body sensation,dyspnea,hoarseness and the average improving time in observation group was significantly better than that in control group,the difference was statistically significant(P<0.05 ).Conclusion Compared with conventional ultrasonic atomization inhalation,the efficacy of budesonide spray atomization inhalation on ear-nose-pharyngeal-throat acute inflammation is better.
ABSTRACT
Objective To investigate the curative effect of ribavirin atomization inhalation on the young children's pneumonia.Methods 224 young children with pneumonia were randomly divided into treatment groups and control group,besides treated with the ordinary therapeutical methods,the treatment group were given ribavirin atomization inhalation 10mg/(kg · d),bid,continued for 7 days,and the control group were given ordinary therapeutical method.Results The treatment group' s curative rate was 91.07％,and the control group' s effective rate was 82.14％,compared with the control group,there was significantly statistical difference(x2 =5.64,P ＜ 0.05).Conclusion Ribavirin atomization inhalation treatment on young child with pneumonia had a higher curative rate and low incidence of adverse reactions,and it was worthy of being widely applied in clinical practice.